Patent Woes Likely To Trigger Drug Co. Losses
The New York Times: Patent Woes Threaten Drug FirmsAt the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company's huge sales (Wilson, 3/6). This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.